Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
3,076,251
-
Shares change
-
-433,335
-
Total reported value, excl. options
-
$274,668,626
-
Value change
-
-$39,232,497
-
Put/Call ratio
-
19%
-
Number of buys
-
34
-
Number of sells
-
-61
-
Price
-
$89.43
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2016
123 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q2 2016.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,076,251 shares
.
Largest 10 shareholders include MORGAN STANLEY (495,811 shares), WELLS FARGO & COMPANY/MN (387,143 shares), BANK OF AMERICA CORP /DE/ (239,351 shares), UBS Group AG (236,590 shares), RAYMOND JAMES & ASSOCIATES (117,166 shares), LPL Financial LLC (109,361 shares), SOCIETE GENERALE (92,206 shares), SG Americas Securities, LLC (92,206 shares), AMERIPRISE FINANCIAL INC (86,931 shares), and J&P(CHINA)CAPITAL MANAGEMENT CO.,LTD (78,537 shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.